Catherine Angell Sohn's Insider Trades & SAST Disclosures

Catherine Angell Sohn's most recent trade in Altimmune Inc was a trade of 18,600 Stock Options (option to buy) done . Disclosure was reported to the exchange on Feb. 6, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Altimmune Inc
Catherine Angell Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2025 18,600 18,600 - - Stock Options (option to buy)
Altimmune Inc
Catherine Angell Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 34,900 34,900 - - Stock Options (option to buy)
Altimmune Inc
Angell Sohn Catherine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2023 26,100 26,100 - - Stock Options (option to buy)
Jazz Pharmaceuticals plc
Catherine Angell Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 3,075 16,109 (0%) 0% 0 Ordinary Shares
Jazz Pharmaceuticals plc
Catherine Angell Sohn Director Sale of securities on an exchange or to another person at price $ 138.16 per share. 11 Aug 2023 1,241 14,868 (0%) 0% 138.2 171,455 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades